Second primary neoplasms among 53 159 haematolymphoproliferative malignancy patients in Sweden, 1958-1996: a search for common mechanisms.
about
Lung cancer and concurrent or sequential lymphoma: Two case reports with hypersensitivity to bevacizumab and a review of the literatureA rare case of acute lymphoblastic leukemia in a patient with light chain (AL) amyloidosis treated with lenalidomide.Peripheral T Cell Non-Hodgkin's Lymphoma following Treatment of Hodgkin's Lymphoma.New cancers after autotransplantations for multiple myeloma.Second cancer incidence and cancer mortality among chronic lymphocytic leukaemia patients: a population-based study.Risk of acute myeloid leukemia and myelodysplastic syndromes after multiple myeloma and its precursor disease (MGUS)Household chemical exposures and the risk of canine malignant lymphoma, a model for human non-Hodgkin's lymphomaSecond malignancies in patients with primary central nervous system lymphoma.Malignant salivary gland tumours of the head and neck region: a single institutions reviewSecond malignancies after multiple myeloma: from 1960s to 2010s.Risk Factors for Melanoma Among Survivors of Non-Hodgkin Lymphoma.Large registry analysis to accurately define second malignancy rates and risks in a well-characterized cohort of 744 consecutive multiple myeloma patients followed-up for 25 years.Autopsy Analysis may Contribute to Establish Actual Incidence of Second Primary Malignancies in Myeloma.Melanoma in immunosuppressed patientsPrimary malignant tumours of bone following previous malignancy.Second primary cancers among 109 000 cases of non-Hodgkin's lymphoma.Review of salivary gland neoplasmsPatterns of second primary malignancy risk in multiple myeloma patients before and after the introduction of novel therapeuticsSecondary malignancies in chronic myeloid leukemia patients after imatinib-based treatment: long-term observation in CML Study IV.Long-term outcome with lenalidomide and dexamethasone therapy for newly diagnosed multiple myeloma.Multiple primary cancers of the colon, rectum, and the thyroid glandA Case-Control Study of Risk Factors for Salivary Gland Cancer in Canada.Therapy-related myeloid neoplasm in non-hodgkin lymphoma survivors.Incidental prostate ¹⁸F-FDG uptake without calcification indicates the possibility of prostate cancer.Second primary malignancies in multiple myeloma: an overview and IMWG consensus.Secondary primary malignancies in multiple myeloma: an old NEMESIS revisited.AML transformation after autologous stem cell transplant for multiple myeloma.Partial remission of acute myeloid leukemia complicating multiple myeloma following COAP chemotherapy: A case report.Carcinoma and multiple lymphomas in one patient: establishing the diagnoses and analyzing risk factors.Development and rapid dissemination of Merkel-cell carcinomatosis following therapy with fludarabine and rituximab for relapsing follicular lymphoma.An Unusual Coexistence of Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma with Endometrioid-Type Endometrial Cancer in a 58-Year-Old Woman: A Case Study with Literature Review.Secondary Salivary Gland Malignancy in Thyroid Cancer: A United States Population Based Study.Ultraviolet Radiation Exposure and Risk of Malignant Lymphomas
P2860
Q28386127-9D172F72-7FFE-44D3-AE9F-D49E71D579B2Q33802749-B35DB5CB-6D83-4251-96D5-5B9A26FB4A6BQ35022610-1C02CEE1-75BD-4E32-A6C0-8D5B88D648CBQ35177465-CA8204BD-F447-4C44-A141-EFF46B64AD3BQ35262838-B50BA59F-BC77-41D1-9E40-7C5D1B18EC8CQ35483580-7511B5C4-C655-4AEC-8DEA-75107F76948AQ35705497-DF5348A6-F9F3-4B5B-B51E-8C83F8A56348Q35788720-BF359D30-8F64-46AC-A4F6-0F4948AE0CDAQ35868436-0E299D01-67A1-4C56-A97B-46DFBC7443D8Q35891594-4E822021-54D0-4EB6-9AB6-2B882D5E45A9Q36090959-F220003F-3053-4C7D-AA0A-83E82542F52CQ36115686-D19E4439-9992-4263-B389-449F6F71D2C5Q36438206-BF1366E9-25ED-4677-94AE-A9B70C3ABC67Q36512842-31F70C52-428E-45B8-91E6-C169114400C6Q36539417-8F86AABF-ABF3-45F4-843B-258408414372Q36614819-29B1B7EC-F520-4C65-A1B2-F5C18CDE66B8Q36857613-ED99B6DC-F0FE-4F8E-BA58-1586A3A5C3A5Q36973705-86F9EE63-DCA3-4665-AEEF-C878110E0FB5Q36974374-34088762-D531-4E83-A447-277041476808Q37228026-3EAAF3C9-9E43-4FE8-A9E1-68484504BBCDQ37243599-A1168D1C-7DB0-4CCA-AD08-D153A3C59305Q37590866-756AD7AE-9209-402B-9DBD-E294C8A9F32BQ37973345-CE29CCE7-E546-4142-BAA6-0872EF45AC9EQ38618098-AE3AAC2B-D34A-4CE8-896B-A9A74450E058Q39013620-4E646AE3-D962-46E4-9BFD-9004A1D8FEADQ39576312-C04DF286-DF93-4F8F-84C0-560B6DA70710Q40153767-4BEB7665-7019-4417-ACF0-357C132EBEBBQ40170328-9D3A2FED-1FE8-4CCD-AB47-7D656041EC41Q42590826-75F44968-8AE3-49AD-AEFC-B2049B098708Q44025145-CA294CA5-CDED-4598-91AD-D04F0DA9EAD1Q55262254-1A4F05E0-E223-482A-94B3-80AF2F4E0633Q55470775-44214E89-0AD1-4310-9248-85B3F1E200FBQ57579886-C4DC1D30-FB95-4B26-AD7C-D1839519322D
P2860
Second primary neoplasms among 53 159 haematolymphoproliferative malignancy patients in Sweden, 1958-1996: a search for common mechanisms.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
2001年论文
@zh
2001年论文
@zh-cn
name
Second primary neoplasms among ...... search for common mechanisms.
@ast
Second primary neoplasms among ...... search for common mechanisms.
@en
type
label
Second primary neoplasms among ...... search for common mechanisms.
@ast
Second primary neoplasms among ...... search for common mechanisms.
@en
prefLabel
Second primary neoplasms among ...... search for common mechanisms.
@ast
Second primary neoplasms among ...... search for common mechanisms.
@en
P2860
P356
P1476
Second primary neoplasms among ...... search for common mechanisms.
@en
P2093
P2860
P304
P356
10.1038/SJ.BJC.6691998
P407
P577
2001-09-01T00:00:00Z